INR:1318. top 20 dragon vs tiger The State Food and Drug Administration issued a document to provide guidance on the control of nitrosamine impurities Sans ...

chhota bheem wallpaper Pfizer's Braftovi two-drug regimen approved for mCRC patients with BRAF V600 mutation India's API 'tightening' and domestic pharmaceutical companies' calmness Luminex submits ...

These five blue-chip dividend stocks are among the best in their respective sectors and are rated Buy at major Wall Street ...

Novo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate. The FDA approved Eli Lilly ...

We recently compiled a list of the 13 Best Dividend Stocks to Buy Under $50. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other dividend stocks. AI ...

The task ahead of Vertex now is to migrate patients already on Trikafta to the new drug. That is supported by data from the ...

INR:0189. rummy jhil Scientists discover a pathway that can extend the lifespan of nematodes by 500% CSPC Pharmaceuticals released its financial report for the first t ...

The US Food and Drug Administration (USFDA) has revoked the emergency use authorisation for four Covid-19 antibody-based ...

Pfizer’s Braftovi (encorafenib) regimen has been granted accelerated approval by the US Food and Drug Administration (FDA) to ...

The accelerated approval is part of the FDA’s Project FrontRunner, aimed at advancing cancer drug development.

US pharma giant Pfizer on Friday revealed that the US Food and Drug Administration (FDA) has approved its Braftovi ...

Pfizer’s BRAFTOVI combination regimen receives US FDA approval for treatment of metastatic colorectal cancer: New York Monday, December 23, 2024, 10:00 Hrs [IST] Pfizer Inc anno ...